化合物PU-H71 T6960

Product Introduction
Bioactivity


英文名: PU-H71

描述: PU-H71是一种选择性的HSP90抑制剂，IC50= 51 nM。

体外活性: PU-H71(1 μ M) 强效抑制三阴性乳腺癌(TNBC)细胞系MDA-MB-468、MDA-MB-231和HCC-1806的生长，其IC50值分别为65、140和87 nM。PU-H71(1 μ M)分别杀死MDA-MB-468、MDA-MB-231和HCC-1806细胞的80%、65%和80%[1]。

体内活性: MDA-MB-231 model treated with PU-H71 at a dose of 75 mg/kg was 100% fully effective. After 37 days of treatment, tumor was replaced by scar tissue, accompanied by a reduction in many proliferative and anti apoptotic molecules, such as EGFR, HER3, Raf-1, Akt, and p-Akt, which decreased by 80%, 95%, 99%, 80%, and 65%, respectively. PU-H71 (75 mg/kg, three times a week) inhibits tumor growth by 96%, reduces tumor cell proliferation by 60%, decreases activated Akt associated with survival and high invasive potential by 85%, and increases apoptosis by 6-fold[1].

存储条件: store at low temperaturePowder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: DMSO : 46.1 mg/mL (89.9 mM)


关键字: PU-H71 | PUH71 | PU H71

相关产品: Luminespib | Apoptozole | 4beta-Hydroxywithanolide E | XL888 | JG-98 | HA15 | AMP-PCP disodium | Geldanamycin | 3-Phenyltoxoflavin | TRAP1-IN-1

化合物PU-H71 T6960信息由TargetMol中国为您提供，如您想了解更多关于化合物PU-H71 T6960报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途